These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1608680

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA, Butler T, Beveridge RA, Kales AN, Binder RA, Smith LJ, Ueno WM, Milkovich G, Goldwater S, Marion A.
    Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
    [Abstract] [Full Text] [Related]

  • 23. Imipenem/cilastatin as secondary therapy for bacterial infections.
    Kono K, Onuki K, Tohara S, Takeda S.
    Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL, Smith JW, Geckler RW, Wilson SE.
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [Abstract] [Full Text] [Related]

  • 28. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F, Faulkner KL.
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993 Sep; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 31. A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
    Matsui K, Masuda N, Takada M, Kusunoki Y, Fukuoka M.
    Jpn J Clin Oncol; 1991 Dec; 21(6):428-34. PubMed ID: 1805048
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical experience with imipenem-cilastatin in intensive therapy].
    Verre M, D'Antona R, Macrina E.
    Clin Ter; 1991 Feb 28; 136(4):273-8. PubMed ID: 1827390
    [Abstract] [Full Text] [Related]

  • 36. Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group.
    Eur J Clin Microbiol Infect Dis; 1992 Aug 28; 11(8):683-92. PubMed ID: 1425726
    [Abstract] [Full Text] [Related]

  • 37. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B, Malmborg AS, Tunevall G, Lindgren V, Bergman L, Mentzing LO, Nyström PO, Anséhn S, Bäckstrand B, Skau T.
    J Antimicrob Chemother; 1995 Jan 28; 35(1):139-48. PubMed ID: 7768761
    [Abstract] [Full Text] [Related]

  • 38. Single dose imipenem-cilastatin compared with three doses of cefuroxime and metronidazole as prophylaxis in elective colorectal surgery: a prospective randomized study.
    Pacelli F, Brisinda G, Bellantone R, Doglietto GB, Crucitti F.
    J Chemother; 1991 Dec 28; 3(6):372-5. PubMed ID: 1819620
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.